2016
DOI: 10.1016/j.ijpharm.2016.07.016
|View full text |Cite
|
Sign up to set email alerts
|

Development and evaluation of viscosity-enhanced nanocarrier (VEN) for oral insulin delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(16 citation statements)
references
References 41 publications
0
14
0
Order By: Relevance
“…(b) A strategy for loading hydrophilic drugs in the core of solid nanoparticles (blue color) by generation of a hydrophilic viscose phase in the core. Reprinted from [101], Copyright (2016), with permission from Elsevier. (c) A two-step preparation method for insulin-loaded core-shell nanoparticles composed of a modified chitosan core coated with thiolated hyaluronic acid through electrostatic [114].…”
Section: Polymeric Nano and Microparticlesmentioning
confidence: 99%
See 1 more Smart Citation
“…(b) A strategy for loading hydrophilic drugs in the core of solid nanoparticles (blue color) by generation of a hydrophilic viscose phase in the core. Reprinted from [101], Copyright (2016), with permission from Elsevier. (c) A two-step preparation method for insulin-loaded core-shell nanoparticles composed of a modified chitosan core coated with thiolated hyaluronic acid through electrostatic [114].…”
Section: Polymeric Nano and Microparticlesmentioning
confidence: 99%
“…In this strategy, the core of orally administered SLNs consists of a solid lipid core and a hydrogen-bonded rich aqueous phase encapsulating insulin, which is either dispersed in the lipid phase or is formed like a central core in the lipid matrix ( Fig. 5 b) [ 101 ]. Although surface functionalization of SLNs with PEG enhances their hydrophilicity, a reduction in muco-adhesion of SLNs is also observed.…”
Section: Micro and Nanoscale Carrier Typesmentioning
confidence: 99%
“…Hecq et al 102 dissolved Ins into the inner aqueous phase and then emulsified in an organic phase to prepare a bioadhesive cationic SLPs, which increased 2.5-fold the transshipment of capped Ins through co-cultured Caco-2/HT29 cells compared to free Ins. Boushra et al 103 adopted three different hydrophilic viscosity-enhancing agents (VAs): propylene glycol (PG), PEG 400 and PEG 600 within SLP cores to develop Ins-loaded NCs with enhanced viscosity. The highest EE was achieved by 70% ( w / w ) PG contained NCs (54.5%) compared to only 20.4% in unmodified SLN and achieved good hypoglycemic effect with a relative bioavailability of 5.1% following oral administration.…”
Section: Lipid-based Particlesmentioning
confidence: 99%
“…The burgeoning field of biomedical engineering has rapidly morphed from basic research into translational medicine, with the application of engineering principles to cancer diagnostics, drug delivery, imaging, and infectious disease detection, to name a few applications (1215). This field, together with genomic analysis, has ushered in personalized medicine in humans.…”
Section: Nanoengineeringmentioning
confidence: 99%